Characterisation of Cdkl5 transcript isoforms in rat
- PMID: 27940108
- DOI: 10.1016/j.gene.2016.12.001
Characterisation of Cdkl5 transcript isoforms in rat
Abstract
CDKL5 deficiency is a severe neurological disorder caused by mutations in the X-linked Cyclin-Dependent Kinase-Like 5 gene (CDKL5). The predominant human CDKL5 brain isoform is a 9.7kb transcript comprised of 18 exons with a large 6.6kb 3'-untranslated region (UTR). Mammalian models of CDKL5 disorder are currently limited to mouse, and little is known about Cdkl5 in other organisms used to model neurodevelopmental disorders, such as rat. In this study we characterise, both bioinformatically and experimentally, the rat Cdkl5 gene structure and its associated transcript isoforms. New exonic regions, splice sites and UTRs are described, confirming the presence of four distinct transcript isoforms. The predominant isoform in the brain, which we name rCdkl5_1, is orthologous to the human hCDKL5_1 and mouse mCdkl5_1 isoforms and is the most highly expressed isoform across all brain regions tested. This updated gene model of Cdkl5 in rat provides a framework for studies into its protein products and provides a reference for the development of molecular therapies for testing in rat models of CDKL5 disorder.
Keywords: CDKL5; CDKL5 disorder; Expression; Neurodevelopmental; Neurological.
Copyright © 2016 Elsevier B.V. All rights reserved.
Similar articles
-
Characterisation of CDKL5 Transcript Isoforms in Human and Mouse.PLoS One. 2016 Jun 17;11(6):e0157758. doi: 10.1371/journal.pone.0157758. eCollection 2016. PLoS One. 2016. PMID: 27315173 Free PMC article.
-
A novel transcript of cyclin-dependent kinase-like 5 (CDKL5) has an alternative C-terminus and is the predominant transcript in brain.Hum Genet. 2012 Feb;131(2):187-200. doi: 10.1007/s00439-011-1058-x. Epub 2011 Jul 12. Hum Genet. 2012. PMID: 21748340
-
Gene replacement ameliorates deficits in mouse and human models of cyclin-dependent kinase-like 5 disorder.Brain. 2020 Mar 1;143(3):811-832. doi: 10.1093/brain/awaa028. Brain. 2020. PMID: 32125365
-
Molecular and Synaptic Bases of CDKL5 Disorder.Dev Neurobiol. 2019 Jan;79(1):8-19. doi: 10.1002/dneu.22639. Epub 2018 Oct 19. Dev Neurobiol. 2019. PMID: 30246934 Review.
-
Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder.Neural Plast. 2020 Jun 5;2020:6970190. doi: 10.1155/2020/6970190. eCollection 2020. Neural Plast. 2020. PMID: 32587608 Free PMC article. Review.
Cited by
-
Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder.Mol Ther. 2024 Oct 2;32(10):3331-3345. doi: 10.1016/j.ymthe.2024.07.012. Epub 2024 Jul 20. Mol Ther. 2024. PMID: 39033321
-
Complex CDKL5 translational regulation and its potential role in CDKL5 deficiency disorder.Front Cell Neurosci. 2023 Oct 30;17:1231493. doi: 10.3389/fncel.2023.1231493. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37964795 Free PMC article.
-
Enhanced hippocampal LTP but normal NMDA receptor and AMPA receptor function in a rat model of CDKL5 deficiency disorder.Mol Autism. 2024 Jun 14;15(1):28. doi: 10.1186/s13229-024-00601-9. Mol Autism. 2024. PMID: 38877552 Free PMC article.
-
Rett and Rett-related disorders: Common mechanisms for shared symptoms?Exp Biol Med (Maywood). 2023 Nov;248(22):2095-2108. doi: 10.1177/15353702231209419. Epub 2023 Dec 6. Exp Biol Med (Maywood). 2023. PMID: 38057990 Free PMC article. Review.
-
Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology.Elife. 2023 Jul 25;12:e88206. doi: 10.7554/eLife.88206. Elife. 2023. PMID: 37490324 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources